(Q35099741)

6 August 2017

1 reference

title

PET in lymphoma: what are the oncologist's needs? (English)

1 reference

6 August 2017

Hoskin PJ

1

1 reference

6 August 2017

publication date

4 April 2003

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

6 August 2017

published in

1 reference

6 August 2017

volume

30 Suppl 1

1 reference

6 August 2017

page(s)

S37-41

1 reference

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

6 August 2017

cites work

1 reference

12 December 2020

FDG PET in the management of lymphoma: a clinical perspective

1 reference

12 December 2020

The price of anticancer intervention. Secondary malignancies after radiotherapy

1 reference

12 December 2020

2-(fluorine-18)fluoro-2-deoxy-D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial

1 reference

12 December 2020

18-FDG-PET as a prognostic indicator in the treatment of aggressive Non-Hodgkin's Lymphoma-comparison with CT

1 reference

12 December 2020

Whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) for accurate staging of Hodgkin's disease

1 reference

12 December 2020

Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma

1 reference

12 December 2020

Current trends in the management of early stage Hodgkin's disease

1 reference

12 December 2020

2-Fluorine-18-fluoro-2-deoxy-D glucose positron emission tomography in the pretreatment staging of Hodgkin's disease: influence on patient management in a single institution

1 reference

12 December 2020

Strategies to reduce deaths from breast cancer following mantle irradiation

1 reference

12 December 2020

Are 18fluorodeoxyglucose positron emission tomography and magnetic resonance imaging useful in the prediction of relapse in lymphoma residual masses?

1 reference

12 December 2020

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease

1 reference

12 December 2020

British National Lymphoma Investigation: pilot studies of neoadjuvant chemotherapy in clinical stage Ia and IIa Hodgkin's disease

1 reference

12 December 2020

Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.

1 reference

12 December 2020

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

1 reference

12 December 2020

10.1007/S00259-003-1158-5

Identifiers

DOI

1 reference

6 August 2017

1 reference